ID   ACAD9_HUMAN             Reviewed;         621 AA.
AC   Q9H845; D3DNB8; Q8WXX3;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-JAN-2026, entry version 199.
DE   RecName: Full=Complex I assembly factor ACAD9, mitochondrial {ECO:0000303|PubMed:24158852};
DE   AltName: Full=Acyl-CoA dehydrogenase family member 9 {ECO:0000303|PubMed:12359260};
DE            Short=ACAD-9 {ECO:0000303|PubMed:12359260};
DE            EC=1.3.8.7 {ECO:0000269|PubMed:16020546};
DE            EC=1.3.8.8 {ECO:0000269|PubMed:12359260, ECO:0000269|PubMed:16020546, ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:24158852};
DE   Flags: Precursor;
GN   Name=ACAD9 {ECO:0000312|HGNC:HGNC:21497};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Dendritic cell;
RX   PubMed=12359260; DOI=10.1016/s0006-291x(02)02336-7;
RA   Zhang J., Zhang W., Zou D., Chen G., Wan T., Zhang M., Cao X.;
RT   "Cloning and functional characterization of ACAD-9, a novel member of human
RT   acyl-CoA dehydrogenase family.";
RL   Biochem. Biophys. Res. Commun. 297:1033-1042(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBSTRATE SPECIFICITY, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, SUBCELLULAR LOCATION, AND CLEAVAGE
RP   OF TRANSIT PEPTIDE AFTER ARG-37.
RX   PubMed=16020546; DOI=10.1074/jbc.m504460200;
RA   Ensenauer R., He M., Willard J.M., Goetzman E.S., Corydon T.J.,
RA   Vandahl B.B., Mohsen A.W., Isaya G., Vockley J.;
RT   "Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial
RT   beta-oxidation of unsaturated fatty acids.";
RL   J. Biol. Chem. 280:32309-32316(2005).
RN   [6]
RP   INVOLVEMENT IN MC1DN20, FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=17564966; DOI=10.1086/519219;
RA   He M., Rutledge S.L., Kelly D.R., Palmer C.A., Murdoch G., Majumder N.,
RA   Nicholls R.D., Pei Z., Watkins P.A., Vockley J.;
RT   "A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9
RT   deficiency.";
RL   Am. J. Hum. Genet. 81:87-103(2007).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-41, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH NDUFAF1 AND ECSIT,
RP   INVOLVEMENT IN MC1DN20, AND VARIANTS MC1DN20 LYS-413 AND HIS-518.
RX   PubMed=20816094; DOI=10.1016/j.cmet.2010.08.002;
RA   Nouws J., Nijtmans L., Houten S.M., van den Brand M., Huynen M.,
RA   Venselaar H., Hoefs S., Gloerich J., Kronick J., Hutchin T., Willems P.,
RA   Rodenburg R., Wanders R., van den Heuvel L., Smeitink J., Vogel R.O.;
RT   "Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative
RT   phosphorylation complex I.";
RL   Cell Metab. 12:283-294(2010).
RN   [9]
RP   INVOLVEMENT IN MC1DN20, AND VARIANTS MC1DN20 ILE-44; TRP-193; PHE-234;
RP   GLN-266; SER-303; THR-326; CYS-417 AND TRP-532.
RX   PubMed=21057504; DOI=10.1038/ng.706;
RA   Haack T.B., Danhauser K., Haberberger B., Hoser J., Strecker V., Boehm D.,
RA   Uziel G., Lamantea E., Invernizzi F., Poulton J., Rolinski B., Iuso A.,
RA   Biskup S., Schmidt T., Mewes H.W., Wittig I., Meitinger T., Zeviani M.,
RA   Prokisch H.;
RT   "Exome sequencing identifies ACAD9 mutations as a cause of complex I
RT   deficiency.";
RL   Nat. Genet. 42:1131-1134(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=21237683; DOI=10.1016/j.ymgme.2010.12.005;
RA   He M., Pei Z., Mohsen A.W., Watkins P., Murdoch G., Van Veldhoven P.P.,
RA   Ensenauer R., Vockley J.;
RT   "Identification and characterization of new long chain acyl-CoA
RT   dehydrogenases.";
RL   Mol. Genet. Metab. 102:418-429(2011).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF GLU-426.
RX   PubMed=24158852; DOI=10.1093/hmg/ddt521;
RA   Nouws J., Te Brinke H., Nijtmans L.G., Houten S.M.;
RT   "ACAD9, a complex I assembly factor with a moonlighting function in fatty
RT   acid oxidation deficiencies.";
RL   Hum. Mol. Genet. 23:1311-1319(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   IDENTIFICATION IN THE MCIA COMPLEX, AND FUNCTION.
RX   PubMed=32320651; DOI=10.1016/j.celrep.2020.107541;
RA   Formosa L.E., Muellner-Wong L., Reljic B., Sharpe A.J., Jackson T.D.,
RA   Beilharz T.H., Stojanovski D., Lazarou M., Stroud D.A., Ryan M.T.;
RT   "Dissecting the Roles of Mitochondrial Complex I Intermediate Assembly
RT   Complex Factors in the Biogenesis of Complex I.";
RL   Cell Rep. 31:107541-107541(2020).
RN   [16]
RP   INTERACTION WITH TMEM70 AND TMEM242.
RX   PubMed=33753518; DOI=10.1073/pnas.2100558118;
RA   Carroll J., He J., Ding S., Fearnley I.M., Walker J.E.;
RT   "TMEM70 and TMEM242 help to assemble the rotor ring of human ATP synthase
RT   and interact with assembly factors for complex I.";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [17]
RP   FUNCTION.
RX   PubMed=38086790; DOI=10.1038/s41467-023-43865-0;
RA   McGregor L., Acajjaoui S., Desfosses A., Saidi M., Bacia-Verloop M.,
RA   Schwarz J.J., Juyoux P., von Velsen J., Bowler M.W., McCarthy A.A.,
RA   Kandiah E., Gutsche I., Soler-Lopez M.;
RT   "The assembly of the Mitochondrial Complex I Assembly complex uncovers a
RT   redox pathway coordination.";
RL   Nat. Commun. 14:8248-8248(2023).
RN   [18]
RP   CATALYTIC ACTIVITY.
RX   PubMed=40255280; DOI=10.1021/acsbiomedchemau.4c00140;
RA   Fabbian S., Masciovecchio B., Schievano E., Giachin G.;
RT   "Hidden beta-gamma Dehydrogenation Products in Long-Chain Fatty Acid
RT   Oxidation Unveiled by NMR: Implications on Lipid Metabolism.";
RL   ACS Bio Med Chem Au 5:262-267(2025).
RN   [19]
RP   VARIANTS MC1DN20 LYS-127; TRP-469 AND TRP-532.
RX   PubMed=20929961; DOI=10.1093/brain/awq273;
RA   Gerards M., van den Bosch B.J., Danhauser K., Serre V., van Weeghel M.,
RA   Wanders R.J., Nicolaes G.A., Sluiter W., Schoonderwoerd K., Scholte H.R.,
RA   Prokisch H., Rotig A., de Coo I.F., Smeets H.J.;
RT   "Riboflavin-responsive oxidative phosphorylation complex I deficiency
RT   caused by defective ACAD9: new function for an old gene.";
RL   Brain 134:210-219(2011).
RN   [20]
RP   VARIANT MC1DN20 TRP-532.
RX   PubMed=22499348; DOI=10.1136/jmedgenet-2012-100846;
RA   Haack T.B., Haberberger B., Frisch E.M., Wieland T., Iuso A., Gorza M.,
RA   Strecker V., Graf E., Mayr J.A., Herberg U., Hennermann J.B., Klopstock T.,
RA   Kuhn K.A., Ahting U., Sperl W., Wilichowski E., Hoffmann G.F., Tesarova M.,
RA   Hansikova H., Zeman J., Plecko B., Zeviani M., Wittig I., Strom T.M.,
RA   Schuelke M., Freisinger P., Meitinger T., Prokisch H.;
RT   "Molecular diagnosis in mitochondrial complex I deficiency using exome
RT   sequencing.";
RL   J. Med. Genet. 49:277-283(2012).
RN   [21]
RP   VARIANT MC1DN20 CYS-414.
RX   PubMed=23836383; DOI=10.1001/jamaneurol.2013.3197;
RA   Garone C., Donati M.A., Sacchini M., Garcia-Diaz B., Bruno C., Calvo S.,
RA   Mootha V.K., Dimauro S.;
RT   "Mitochondrial encephalomyopathy due to a novel mutation in ACAD9.";
RL   JAMA Neurol. 70:1177-1179(2013).
RN   [22]
RP   VARIANT MC1DN20 VAL-220.
RX   PubMed=23996478; DOI=10.1007/8904_2013_242;
RA   Nouws J., Wibrand F., van den Brand M., Venselaar H., Duno M., Lund A.M.,
RA   Trautner S., Nijtmans L., Ostergard E.;
RT   "A patient with complex I deficiency caused by a novel ACAD9 mutation not
RT   responding to riboflavin treatment.";
RL   JIMD Rep. 12:37-45(2014).
RN   [23]
RP   VARIANTS MC1DN20 GLY-271; MET-384 AND HIS-606.
RX   PubMed=26741492; DOI=10.1371/journal.pgen.1005679;
RA   Kohda M., Tokuzawa Y., Kishita Y., Nyuzuki H., Moriyama Y., Mizuno Y.,
RA   Hirata T., Yatsuka Y., Yamashita-Sugahara Y., Nakachi Y., Kato H.,
RA   Okuda A., Tamaru S., Borna N.N., Banshoya K., Aigaki T., Sato-Miyata Y.,
RA   Ohnuma K., Suzuki T., Nagao A., Maehata H., Matsuda F., Higasa K.,
RA   Nagasaki M., Yasuda J., Yamamoto M., Fushimi T., Shimura M.,
RA   Kaiho-Ichimoto K., Harashima H., Yamazaki T., Mori M., Murayama K.,
RA   Ohtake A., Okazaki Y.;
RT   "A comprehensive genomic analysis reveals the genetic landscape of
RT   mitochondrial respiratory chain complex deficiencies.";
RL   PLoS Genet. 12:E1005679-E1005679(2016).
CC   -!- FUNCTION: Together with NDUFAF1 and ECSIT, forms part of the
CC       mitochondrial complex I (MCIA),which is required for the biogenesis of
CC       respiratory Complex I (CI) and is therefore crucial for the activation
CC       of the oxidative phosphorylation system (PubMed:20816094,
CC       PubMed:24158852, PubMed:32320651, PubMed:38086790). ECSIT binding
CC       triggers a large conformational change, switching ACAD9 from a fatty
CC       acid oxidation (FAO) enzyme to a CI assembly factor (PubMed:38086790).
CC       The function in CI assembly is independent of the FAO activity of the
CC       protein (PubMed:24158852). As FAO enzyme, it catalyzes the first step
CC       in FAO, which consists in the proR-proR stereospecific alpha, beta-
CC       dehydrogenation of fatty acyl-CoA thioesters using the electron
CC       transfer flavoprotein (ETF) as their physiologic electron acceptor,
CC       resulting in the formation of trans-2-enoyl-CoA ((2E)-enoyl-CoA)
CC       (PubMed:12359260, PubMed:16020546, PubMed:17564966, PubMed:21237683,
CC       PubMed:24158852). Its preferred substrates are both saturated and
CC       unsaturated long-chain acyl-CoA substrates, with optimum activity
CC       toward the latter (PubMed:12359260, PubMed:16020546, PubMed:17564966,
CC       PubMed:21237683, PubMed:24158852). Among the different mitochondrial
CC       acyl-CoA dehydrogenases, its FAO activity overlaps with that of ACADV
CC       and ACADL, but plays a primary role in tissues where it is the main
CC       long-chain ACAD expressed, such as the central nervous system
CC       (PubMed:16020546, PubMed:17564966, PubMed:24158852).
CC       {ECO:0000269|PubMed:12359260, ECO:0000269|PubMed:16020546,
CC       ECO:0000269|PubMed:17564966, ECO:0000269|PubMed:20816094,
CC       ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:24158852,
CC       ECO:0000269|PubMed:32320651, ECO:0000269|PubMed:38086790}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain 2,3-saturated fatty acyl-CoA + oxidized
CC         [electron-transfer flavoprotein] + H(+) = a long-chain (2E)-enoyl-CoA
CC         + reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:17721,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:83721,
CC         ChEBI:CHEBI:83727; EC=1.3.8.8; Evidence={ECO:0000269|PubMed:12359260,
CC         ECO:0000269|PubMed:16020546, ECO:0000269|PubMed:17564966,
CC         ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:24158852,
CC         ECO:0000269|PubMed:40255280};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17722;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a medium-chain 2,3-saturated fatty acyl-CoA + oxidized
CC         [electron-transfer flavoprotein] + H(+) = a medium-chain (2E)-enoyl-
CC         CoA + reduced [electron-transfer flavoprotein]; Xref=Rhea:RHEA:14477,
CC         Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:83723,
CC         ChEBI:CHEBI:83726; EC=1.3.8.7;
CC         Evidence={ECO:0000269|PubMed:16020546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14478;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=nonanoyl-CoA + oxidized [electron-transfer flavoprotein] +
CC         H(+) = (2E)-nonenoyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:48208, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:76291, ChEBI:CHEBI:76292;
CC         Evidence={ECO:0000269|PubMed:16020546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48209;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=decanoyl-CoA + oxidized [electron-transfer flavoprotein] +
CC         H(+) = (2E)-decenoyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:48176, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:61406, ChEBI:CHEBI:61430;
CC         Evidence={ECO:0000269|PubMed:16020546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48177;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=undecanoyl-CoA + oxidized [electron-transfer flavoprotein] +
CC         H(+) = trans-2-undecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48200, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:77547, ChEBI:CHEBI:77548;
CC         Evidence={ECO:0000269|PubMed:16020546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48201;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=tetradecanoyl-CoA + oxidized [electron-transfer flavoprotein]
CC         + H(+) = (2E)-tetradecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47316, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57385, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:61405;
CC         Evidence={ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47317;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=pentadecanoyl-CoA + oxidized [electron-transfer flavoprotein]
CC         + H(+) = (2E)-pentadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48204, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:74309, ChEBI:CHEBI:77545;
CC         Evidence={ECO:0000269|PubMed:16020546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48205;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=oxidized [electron-transfer flavoprotein] + hexadecanoyl-CoA +
CC         H(+) = (2E)-hexadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:43448, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57379, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:61526;
CC         Evidence={ECO:0000269|PubMed:12359260, ECO:0000269|PubMed:16020546,
CC         ECO:0000269|PubMed:21237683, ECO:0000269|PubMed:24158852,
CC         ECO:0000269|PubMed:40255280};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43449;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=heptadecanoyl-CoA + oxidized [electron-transfer flavoprotein]
CC         + H(+) = trans-2-heptadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:48196, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:74307, ChEBI:CHEBI:77551;
CC         Evidence={ECO:0000269|PubMed:16020546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48197;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=octadecanoyl-CoA + oxidized [electron-transfer flavoprotein] +
CC         H(+) = (2E)-octadecenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47240, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57394, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:71412;
CC         Evidence={ECO:0000269|PubMed:12359260, ECO:0000269|PubMed:16020546,
CC         ECO:0000269|PubMed:17564966, ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47241;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eicosanoyl-CoA + oxidized [electron-transfer flavoprotein] +
CC         H(+) = (2E)-eicosenoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47236, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57380, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:74691;
CC         Evidence={ECO:0000269|PubMed:16020546, ECO:0000269|PubMed:21237683};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47237;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-hexadecenoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] + H(+) = (2E,9Z)-hexadecadienoyl-CoA + reduced
CC         [electron-transfer flavoprotein]; Xref=Rhea:RHEA:47304, Rhea:RHEA-
CC         COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:61540,
CC         ChEBI:CHEBI:77549; Evidence={ECO:0000269|PubMed:16020546,
CC         ECO:0000269|PubMed:17564966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47305;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9E)-octadecenoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] + H(+) = (2E,9E)-octadecadienoyl-CoA + reduced
CC         [electron-transfer flavoprotein]; Xref=Rhea:RHEA:48192, Rhea:RHEA-
CC         COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57692, ChEBI:CHEBI:58307, ChEBI:CHEBI:77537,
CC         ChEBI:CHEBI:77552; Evidence={ECO:0000269|PubMed:16020546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48193;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=oxidized [electron-transfer flavoprotein] + (9Z)-octadecenoyl-
CC         CoA + H(+) = (2E,9Z)-octadecadienoyl-CoA + reduced [electron-transfer
CC         flavoprotein]; Xref=Rhea:RHEA:47300, Rhea:RHEA-COMP:10685, Rhea:RHEA-
CC         COMP:10686, ChEBI:CHEBI:15378, ChEBI:CHEBI:57387, ChEBI:CHEBI:57692,
CC         ChEBI:CHEBI:58307, ChEBI:CHEBI:77553;
CC         Evidence={ECO:0000269|PubMed:16020546, ECO:0000269|PubMed:17564966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47301;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + oxidized [electron-transfer
CC         flavoprotein] + H(+) = (2E,9Z,12Z)-octadecatrienoyl-CoA + reduced
CC         [electron-transfer flavoprotein]; Xref=Rhea:RHEA:48188, Rhea:RHEA-
CC         COMP:10685, Rhea:RHEA-COMP:10686, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57383, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:77558; Evidence={ECO:0000269|PubMed:16020546};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48189;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA + oxidized
CC         [electron-transfer flavoprotein] + H(+) = (2E,4Z,7Z,10Z,13Z,16Z,19Z)-
CC         docosaheptaenoyl-CoA + reduced [electron-transfer flavoprotein];
CC         Xref=Rhea:RHEA:48184, Rhea:RHEA-COMP:10685, Rhea:RHEA-COMP:10686,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57692, ChEBI:CHEBI:58307,
CC         ChEBI:CHEBI:74298, ChEBI:CHEBI:77559;
CC         Evidence={ECO:0000269|PubMed:16020546, ECO:0000269|PubMed:17564966};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48185;
CC         Evidence={ECO:0000305|PubMed:24158852};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000305|PubMed:16020546};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.8 uM for hexadecanoyl-CoA {ECO:0000269|PubMed:16020546};
CC         KM=0.7 uM for (9Z)-hexadecenoyl-CoA {ECO:0000269|PubMed:16020546};
CC         KM=2.1 uM for (9Z,12Z)-octadecadienoyl-CoA
CC         {ECO:0000269|PubMed:16020546};
CC   -!- SUBUNIT: Homodimer (PubMed:16020546). Interacts with NDUFAF1 and ECSIT
CC       (PubMed:20816094). Part of the mitochondrial complex I assembly/MCIA
CC       complex that comprises at least the core subunits TMEM126B, NDUFAF1,
CC       ECSIT and ACAD9 and complement subunits such as COA1 and TMEM186
CC       (PubMed:32320651). Interacts with TMEM70 and TMEM242 (PubMed:33753518).
CC       {ECO:0000269|PubMed:16020546, ECO:0000269|PubMed:20816094,
CC       ECO:0000269|PubMed:32320651, ECO:0000269|PubMed:33753518}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:16020546, ECO:0000269|PubMed:20816094}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:16020546}; Matrix side
CC       {ECO:0000269|PubMed:16020546}. Note=Essentially associated with
CC       membranes. {ECO:0000269|PubMed:16020546}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in most normal human tissues
CC       and cancer cell lines with higher levels in heart, skeletal muscles,
CC       and the central nervous system (where it is the highest expressed ACAD)
CC       (PubMed:12359260, PubMed:17564966). Highly expressed (at protein level)
CC       in the cerebellum (Purkinje neurons, dentate nucleus, and in the
CC       granular layer), where ACADV is not found (PubMed:17564966,
CC       PubMed:21237683). {ECO:0000269|PubMed:12359260,
CC       ECO:0000269|PubMed:17564966, ECO:0000269|PubMed:21237683}.
CC   -!- DISEASE: Mitochondrial complex I deficiency, nuclear type 20 (MC1DN20)
CC       [MIM:611126]: An autosomal recessive metabolic disorder associated with
CC       mitochondrial complex I deficiency, resulting in multisystemic and
CC       variable manifestations. Clinical features include infantile onset of
CC       acute metabolic acidosis, Reye-like episodes (brain edema and vomiting
CC       that may rapidly progress to seizures, coma and death), exercise
CC       intolerance, hypertrophic cardiomyopathy, liver failure, muscle
CC       weakness, and neurologic dysfunction. {ECO:0000269|PubMed:17564966,
CC       ECO:0000269|PubMed:20816094, ECO:0000269|PubMed:20929961,
CC       ECO:0000269|PubMed:21057504, ECO:0000269|PubMed:22499348,
CC       ECO:0000269|PubMed:23836383, ECO:0000269|PubMed:23996478,
CC       ECO:0000269|PubMed:26741492}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF327351; AAL56011.1; -; mRNA.
DR   EMBL; AK024012; BAB14775.1; -; mRNA.
DR   EMBL; CH471052; EAW79295.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79296.1; -; Genomic_DNA.
DR   EMBL; BC013354; AAH13354.1; -; mRNA.
DR   EMBL; BC007970; AAH07970.1; -; mRNA.
DR   CCDS; CCDS3053.1; -.
DR   PIR; JC7892; JC7892.
DR   RefSeq; NP_054768.2; NM_014049.4.
DR   PDB; 8PHE; EM; 3.10 A; A/B=38-621.
DR   PDB; 8PHF; EM; 3.60 A; A/B=38-621.
DR   PDBsum; 8PHE; -.
DR   PDBsum; 8PHF; -.
DR   AlphaFoldDB; Q9H845; -.
DR   EMDB; EMD-17659; -.
DR   EMDB; EMD-17660; -.
DR   EMDB; EMD-17661; -.
DR   SASBDB; Q9H845; -.
DR   SMR; Q9H845; -.
DR   BioGRID; 118799; 464.
DR   ComplexPortal; CPX-6322; Mitochondrial complex I intermediate assembly (MCIA) complex.
DR   DIP; DIP-53699N; -.
DR   FunCoup; Q9H845; 1888.
DR   IntAct; Q9H845; 145.
DR   MINT; Q9H845; -.
DR   STRING; 9606.ENSP00000312618; -.
DR   SwissLipids; SLP:000000619; -.
DR   GlyGen; Q9H845; 4 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (3 sites).
DR   iPTMnet; Q9H845; -.
DR   MetOSite; Q9H845; -.
DR   PhosphoSitePlus; Q9H845; -.
DR   SwissPalm; Q9H845; -.
DR   BioMuta; ACAD9; -.
DR   DMDM; 32469596; -.
DR   jPOST; Q9H845; -.
DR   MassIVE; Q9H845; -.
DR   PaxDb; 9606-ENSP00000312618; -.
DR   PeptideAtlas; Q9H845; -.
DR   ProteomicsDB; 81177; -.
DR   Pumba; Q9H845; -.
DR   Antibodypedia; 33213; 171 antibodies from 25 providers.
DR   DNASU; 28976; -.
DR   Ensembl; ENST00000308982.12; ENSP00000312618.7; ENSG00000177646.21.
DR   Ensembl; ENST00000681583.1; ENSP00000506340.1; ENSG00000177646.21.
DR   GeneID; 28976; -.
DR   KEGG; hsa:28976; -.
DR   MANE-Select; ENST00000308982.12; ENSP00000312618.7; NM_014049.5; NP_054768.2.
DR   UCSC; uc003ela.5; human.
DR   AGR; HGNC:21497; -.
DR   ClinPGx; PA134900655; -.
DR   CTD; 28976; -.
DR   DisGeNET; 28976; -.
DR   GeneCards; ACAD9; -.
DR   HGNC; HGNC:21497; ACAD9.
DR   HPA; ENSG00000177646; Low tissue specificity.
DR   MalaCards; ACAD9; -.
DR   MIM; 611103; gene.
DR   MIM; 611126; phenotype.
DR   OpenTargets; ENSG00000177646; -.
DR   Orphanet; 99901; Acyl-CoA dehydrogenase 9 deficiency.
DR   VEuPathDB; HostDB:ENSG00000177646; -.
DR   eggNOG; KOG0137; Eukaryota.
DR   GeneTree; ENSGT00940000157312; -.
DR   HOGENOM; CLU_018204_11_2_1; -.
DR   InParanoid; Q9H845; -.
DR   OMA; CDLANDW; -.
DR   OrthoDB; 2588832at2759; -.
DR   PAN-GO; Q9H845; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9H845; -.
DR   PathwayCommons; Q9H845; -.
DR   Reactome; R-HSA-6799198; Complex I biogenesis.
DR   SABIO-RK; Q9H845; -.
DR   SignaLink; Q9H845; -.
DR   Agora; ENSG00000177646; -.
DR   BioGRID-ORCS; 28976; 103 hits in 1173 CRISPR screens.
DR   GeneWiki; ACAD9; -.
DR   GenomeRNAi; 28976; -.
DR   Pharos; Q9H845; Tbio.
DR   PRO; PR:Q9H845; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9H845; protein.
DR   Bgee; ENSG00000177646; Expressed in upper arm skin and 178 other cell types or tissues.
DR   ExpressionAtlas; Q9H845; baseline and differential.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IDA:FlyBase.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0004466; F:long-chain fatty acyl-CoA dehydrogenase activity; IDA:BHF-UCL.
DR   GO; GO:0070991; F:medium-chain fatty acyl-CoA dehydrogenase activity; IDA:BHF-UCL.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0051791; P:medium-chain fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB.
DR   CDD; cd01161; VLCAD; 1.
DR   FunFam; 1.20.140.10:FF:000023; Acyl-CoA dehydrogenase family member 9; 1.
DR   FunFam; 1.20.140.10:FF:000008; acyl-CoA dehydrogenase family member 9, mitochondrial; 1.
DR   FunFam; 2.40.110.10:FF:000006; very long-chain specific acyl-CoA dehydrogenase, mitochondrial; 1.
DR   FunFam; 1.10.540.10:FF:000001; Very long-chain-specific acyl-CoA dehydrogenase, mitochondrial; 1.
DR   Gene3D; 1.10.540.10; Acyl-CoA dehydrogenase/oxidase, N-terminal domain; 1.
DR   Gene3D; 2.40.110.10; Butyryl-CoA Dehydrogenase, subunit A, domain 2; 1.
DR   Gene3D; 1.20.140.10; Butyryl-CoA Dehydrogenase, subunit A, domain 3; 2.
DR   InterPro; IPR049448; ACAD9/ACADV-like_C.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_mid-dom.
DR   InterPro; IPR046373; Acyl-CoA_Oxase/DH_mid-dom_sf.
DR   InterPro; IPR036250; AcylCo_DH-like_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR037069; AcylCoA_DH/ox_N_sf.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom_sf.
DR   PANTHER; PTHR43884; ACYL-COA DEHYDROGENASE; 1.
DR   PANTHER; PTHR43884:SF9; COMPLEX I ASSEMBLY FACTOR ACAD9, MITOCHONDRIAL; 1.
DR   Pfam; PF21343; ACAD9-ACADV_C; 1.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; Acyl-CoA dehydrogenase C-terminal domain-like; 2.
DR   SUPFAM; SSF56645; Acyl-CoA dehydrogenase NM domain-like; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Disease variant; FAD; Flavoprotein; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Oxidoreductase;
KW   Phosphoprotein; Primary mitochondrial disease; Proteomics identification;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..37
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:16020546"
FT   CHAIN           38..621
FT                   /note="Complex I assembly factor ACAD9, mitochondrial"
FT                   /id="PRO_0000000524"
FT   ACT_SITE        426
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:24158852"
FT   MOD_RES         41
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         92
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZN5"
FT   MOD_RES         478
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZN5"
FT   MOD_RES         521
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZN5"
FT   MOD_RES         521
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8JZN5"
FT   VARIANT         44
FT                   /note="F -> I (in MC1DN20; dbSNP:rs387907041)"
FT                   /evidence="ECO:0000269|PubMed:21057504"
FT                   /id="VAR_071892"
FT   VARIANT         127
FT                   /note="R -> K (in MC1DN20)"
FT                   /evidence="ECO:0000269|PubMed:20929961"
FT                   /id="VAR_071893"
FT   VARIANT         193
FT                   /note="R -> W (in MC1DN20; uncertain significance;
FT                   dbSNP:rs377547811)"
FT                   /evidence="ECO:0000269|PubMed:21057504"
FT                   /id="VAR_071894"
FT   VARIANT         220
FT                   /note="A -> V (in MC1DN20)"
FT                   /evidence="ECO:0000269|PubMed:23996478"
FT                   /id="VAR_071895"
FT   VARIANT         234
FT                   /note="S -> F (in MC1DN20; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:21057504"
FT                   /id="VAR_071896"
FT   VARIANT         266
FT                   /note="R -> Q (in MC1DN20; dbSNP:rs387907042)"
FT                   /evidence="ECO:0000269|PubMed:21057504"
FT                   /id="VAR_071897"
FT   VARIANT         271
FT                   /note="C -> G (in MC1DN20)"
FT                   /evidence="ECO:0000269|PubMed:26741492"
FT                   /id="VAR_076177"
FT   VARIANT         303
FT                   /note="G -> S (in MC1DN20; uncertain significance;
FT                   dbSNP:rs143383023)"
FT                   /evidence="ECO:0000269|PubMed:21057504"
FT                   /id="VAR_071898"
FT   VARIANT         326
FT                   /note="A -> T (in MC1DN20; likely benign;
FT                   dbSNP:rs115532916)"
FT                   /evidence="ECO:0000269|PubMed:21057504"
FT                   /id="VAR_071899"
FT   VARIANT         384
FT                   /note="V -> M (in MC1DN20; dbSNP:rs1447947184)"
FT                   /evidence="ECO:0000269|PubMed:26741492"
FT                   /id="VAR_076178"
FT   VARIANT         413
FT                   /note="E -> K (in MC1DN20; uncertain significance;
FT                   dbSNP:rs149753643)"
FT                   /evidence="ECO:0000269|PubMed:20816094"
FT                   /id="VAR_071900"
FT   VARIANT         414
FT                   /note="R -> C (in MC1DN20; dbSNP:rs777282696)"
FT                   /evidence="ECO:0000269|PubMed:23836383"
FT                   /id="VAR_071901"
FT   VARIANT         417
FT                   /note="R -> C (in MC1DN20; dbSNP:rs368949613)"
FT                   /evidence="ECO:0000269|PubMed:21057504"
FT                   /id="VAR_071902"
FT   VARIANT         469
FT                   /note="R -> W (in MC1DN20; dbSNP:rs139145143)"
FT                   /evidence="ECO:0000269|PubMed:20929961"
FT                   /id="VAR_071903"
FT   VARIANT         477
FT                   /note="R -> Q (in dbSNP:rs4494951)"
FT                   /id="VAR_033459"
FT   VARIANT         518
FT                   /note="R -> H (in MC1DN20; dbSNP:rs781149699)"
FT                   /evidence="ECO:0000269|PubMed:20816094"
FT                   /id="VAR_071904"
FT   VARIANT         532
FT                   /note="R -> W (in MC1DN20; dbSNP:rs377022708)"
FT                   /evidence="ECO:0000269|PubMed:20929961,
FT                   ECO:0000269|PubMed:21057504, ECO:0000269|PubMed:22499348"
FT                   /id="VAR_071905"
FT   VARIANT         606
FT                   /note="L -> H (in MC1DN20)"
FT                   /evidence="ECO:0000269|PubMed:26741492"
FT                   /id="VAR_076179"
FT   MUTAGEN         426
FT                   /note="E->Q: Loss of long-chain-acyl-CoA dehydrogenase
FT                   activity. Does not affect mitochondrial complex I
FT                   assembly."
FT                   /evidence="ECO:0000269|PubMed:24158852"
FT   CONFLICT        397
FT                   /note="A -> V (in Ref. 1; AAL56011)"
FT                   /evidence="ECO:0000305"
FT   HELIX           40..43
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   TURN            44..46
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          52..55
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           61..70
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           75..80
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           84..90
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           95..104
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   TURN            105..107
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          108..111
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           113..115
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           122..132
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          135..137
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           138..146
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   TURN            147..150
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           151..156
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           159..170
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          176..179
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          185..191
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          195..198
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          202..215
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   TURN            216..219
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          221..230
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          240..248
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           249..251
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          270..281
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          285..288
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   TURN            289..292
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           293..302
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           307..327
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          330..335
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           336..338
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           340..367
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          369..371
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           376..400
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           402..404
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           413..418
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           419..423
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   STRAND          425..427
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           429..452
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           492..494
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           495..519
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           520..524
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           527..556
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           561..584
FT                   /evidence="ECO:0007829|PDB:8PHE"
FT   HELIX           596..608
FT                   /evidence="ECO:0007829|PDB:8PHE"
SQ   SEQUENCE   621 AA;  68760 MW;  064BCE0378877F54 CRC64;
     MSGCGLFLRT TAAARACRGL VVSTANRRLL RTSPPVRAFA KELFLGKIKK KEVFPFPEVS
     QDELNEINQF LGPVEKFFTE EVDSRKIDQE GKIPDETLEK LKSLGLFGLQ VPEEYGGLGF
     SNTMYSRLGE IISMDGSITV TLAAHQAIGL KGIILAGTEE QKAKYLPKLA SGEHIAAFCL
     TEPASGSDAA SIRSRATLSE DKKHYILNGS KVWITNGGLA NIFTVFAKTE VVDSDGSVKD
     KITAFIVERD FGGVTNGKPE DKLGIRGSNT CEVHFENTKI PVENILGEVG DGFKVAMNIL
     NSGRFSMGSV VAGLLKRLIE MTAEYACTRK QFNKRLSEFG LIQEKFALMA QKAYVMESMT
     YLTAGMLDQP GFPDCSIEAA MVKVFSSEAA WQCVSEALQI LGGLGYTRDY PYERILRDTR
     ILLIFEGTNE ILRMYIALTG LQHAGRILTT RIHELKQAKV STVMDTVGRR LRDSLGRTVD
     LGLTGNHGVV HPSLADSANK FEENTYCFGR TVETLLLRFG KTIMEEQLVL KRVANILINL
     YGMTAVLSRA SRSIRIGLRN HDHEVLLANT FCVEAYLQNL FSLSQLDKYA PENLDEQIKK
     VSQQILEKRA YICAHPLDRT C
//
